Status:
COMPLETED
GLucose Monitoring Programme SingaporeE (GLiMPSE)
Lead Sponsor:
Singapore General Hospital
Collaborating Sponsors:
KK Women's and Children's Hospital
SingHealth Polyclinics
Conditions:
Diabetes Mellitus, Type 2
Eligibility:
All Genders
12-75 years
Phase:
NA
Brief Summary
This phase 1 study is a non-randomized, single-arm, multi-center study that is designed to evaluate the feasibility and acceptability of the flash glucose monitoring system together with a structured ...
Detailed Description
Up to 30 adults and 15 children will be recruited from 3 different sites in Singapore. For Adults, this phase consists of screening and intervention periods. Screening Period (Week -2 to -1): Parti...
Eligibility Criteria
Inclusion
- Adults
- Adults (Age \> 21 years) with Type 2 diabetes (HbA1c 8 to 10% at time of enrolment)
- Singapore Citizen or Permanent Resident
- Treatment with diet and exercise alone or other glucose-lowering therapies except prandial insulin. GLP-1 agonists and / or basal insulin (NPH insulin, Insulin Lantus, Insulin Toujeo, Insulin Detemir) are permitted.
- Self-reported regular blood glucose testing via CBG (more than 3/week)
- Children
- Children and adolescents (Age between 12 and 21 years old) with Type 2 diabetes and HbA1c \>8% at the time of enrolment
- Singapore Citizen or Permanent Resident
- Insulin replacement as part of diabetes management
Exclusion
- Age above 75 years
- Type 1 diabetes, monogenic diabetes
- Prandial insulin (quick-acting insulin or premixed insulin)
- Cancer requiring treatment in the past 5 years
- Chronic renal failure (eGFR\<45ml/min) or dialysis
- Amputation of lower limbs (excluding toe amputations)
- Bariatric surgery for weight loss
- Current systemic treatment with steroids
- Pregnancy, attempting pregnancy or lactation.
- Haemolytic anaemia or haemoglobinopathy
- Prior use of the flash glucose monitoring system
Key Trial Info
Start Date :
March 25 2019
Trial Type :
INTERVENTIONAL
Allocation :
ACTUAL
End Date :
April 30 2020
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT03837262
Start Date
March 25 2019
End Date
April 30 2020
Last Update
September 9 2020
Active Locations (3)
Enter a location and click search to find clinical trials sorted by distance.
1
Singapore General Hospital
Singapore, Singapore, 169856
2
KKH
Singapore, Singapore, 229899
3
Pasir Ris Polyclinic
Singapore, Singapore, 519457